Conclusion:The strategy of ALG+CsA+MMF+Pred is safe, effective and better than that of CsA+Aza+Pred for the long-term recipient/graft survival of elder patients with KT.

• 高脂血症发生率 70%25vs 4 5 .；8%25；有显著差异 (P <0